Player FM uygulamasıyla çevrimdışı Player FM !
Nov 22 2024 This Week in Cardiology
Manage episode 451534540 series 2794872
An AHA review: the OPTION, SUMMIT, VANISH 2, SARAH, and CLEAR trials are the topics John Mandrola, MD, discusses in this week’s podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. OPTION Trial
For AF, LAA Rivals Anticoagulants After Ablation
https://www.medscape.com/viewarticle/af-laa-rivals-anticoagulants-after-ablation-2024a1000l7n
4 Reasons to Question Percutaneous Left Atrial Appendage Closure After AF Ablation
- OPTION in NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2408308
II. SUMMIT Trial
Tirzepatide Reduces Heart Failure Events in HFpEF With Obesity
- SUMMIT in NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2410027
III. VANISH Trial
New Trial Result Pushes Past Antiarrhythmic Therapy After MI
- VANISH 2 https://www.nejm.org/doi/full/10.1056/NEJMoa2409501
- VANISH 1 https://www.nejm.org/doi/full/10.1056/NEJMoa1513614
IV. Cardioprotection
Common Heart Failure Drugs Ease Heart Damage During Chemo https://www.medscape.com/viewarticle/common-heart-failure-drugs-ease-heart-damage-during-chemo-2024a1000l14
- Strain Imaging Review Article https://www.jacc.org/doi/10.1016/j.jcmg.2024.07.011
V. CLEAR trial
Spironolactone Shows Mixed Results in Acute MI
https://www.medscape.com/viewarticle/spironolactone-shows-mixed-results-acute-mi-2024a1000l41
Routine Colchicine or MRA Post-MI: No CLEAR Benefit
https://www.medscape.com/viewarticle/routine-colchicine-or-mra-post-mi-no-clear-benefit-2024a1000la2
- CLEAR-Spironolactone https://www.nejm.org/doi/full/10.1056/NEJMoa2405923
- CLEAR-Colchicine https://www.nejm.org/doi/full/10.1056/NEJMoa2405922
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
344 bölüm
Manage episode 451534540 series 2794872
An AHA review: the OPTION, SUMMIT, VANISH 2, SARAH, and CLEAR trials are the topics John Mandrola, MD, discusses in this week’s podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. OPTION Trial
For AF, LAA Rivals Anticoagulants After Ablation
https://www.medscape.com/viewarticle/af-laa-rivals-anticoagulants-after-ablation-2024a1000l7n
4 Reasons to Question Percutaneous Left Atrial Appendage Closure After AF Ablation
- OPTION in NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2408308
II. SUMMIT Trial
Tirzepatide Reduces Heart Failure Events in HFpEF With Obesity
- SUMMIT in NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2410027
III. VANISH Trial
New Trial Result Pushes Past Antiarrhythmic Therapy After MI
- VANISH 2 https://www.nejm.org/doi/full/10.1056/NEJMoa2409501
- VANISH 1 https://www.nejm.org/doi/full/10.1056/NEJMoa1513614
IV. Cardioprotection
Common Heart Failure Drugs Ease Heart Damage During Chemo https://www.medscape.com/viewarticle/common-heart-failure-drugs-ease-heart-damage-during-chemo-2024a1000l14
- Strain Imaging Review Article https://www.jacc.org/doi/10.1016/j.jcmg.2024.07.011
V. CLEAR trial
Spironolactone Shows Mixed Results in Acute MI
https://www.medscape.com/viewarticle/spironolactone-shows-mixed-results-acute-mi-2024a1000l41
Routine Colchicine or MRA Post-MI: No CLEAR Benefit
https://www.medscape.com/viewarticle/routine-colchicine-or-mra-post-mi-no-clear-benefit-2024a1000la2
- CLEAR-Spironolactone https://www.nejm.org/doi/full/10.1056/NEJMoa2405923
- CLEAR-Colchicine https://www.nejm.org/doi/full/10.1056/NEJMoa2405922
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
344 bölüm
All episodes
×Player FM'e Hoş Geldiniz!
Player FM şu anda sizin için internetteki yüksek kalitedeki podcast'leri arıyor. En iyi podcast uygulaması ve Android, iPhone ve internet üzerinde çalışıyor. Aboneliklerinizi cihazlar arasında eş zamanlamak için üye olun.